Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release – PR Newswire

PR Newswire

Image Credit: PR Newswire

Please find more details at PR Newswire

Summary

Zoom conference call scheduled for March 5, 2026, 9:00 AM ET

REHOVOT, Israel, Feb. 19, 2026 /PRNewswire/ — Evogene Ltd . (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural in…

Source: PR Newswire

Read More

(0)

Exclusive AI-Powered News Insights (For Members only)

Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!